FDA panel backs approval of GSK asthma drug in adults
June 11, 2015 at 15:32 PM EDT
June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug for severe asthma in patients aged 18 and older.